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Introduction: In systemic lupus erythematosus, acute kidney injury is usually associated with severe lupus nephritis
and rarely associated with other glomerular diseases.
Case presentation: We recently encountered a patient with acute kidney injury that was associated with minimal
change disease in systemic lupus erythematosus. A 26-year-old Chinese woman who had a history of systemic
lupus erythematosus presented with nephrotic syndrome and acute kidney injury. She fulfilled four of the American
College of Rheumatology criteria for the classification of systemic lupus erythematosus. However, a renal biopsy
revealed that there were no glomerular abnormalities or deposition of immune complex. Her generalized edema
disappeared, and her high serum creatinine level decreased to normal after prednisolone therapy.
Conclusion: Though the relationship between lupus and minimal change disease is still not defined, the possibility
of systemic lupus erythematosus combined with minimal change disease must be differentiated in patients with
lupus and severe proteinuria.
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Systemic lupus erythematosus (SLE) is an autoimmune
disease characterized by pathogenic autoantibodies and
deposition of immune complexes in various organs. Lupus
nephritis (LN) is caused by immune complex deposition
in the glomerulus [1].
Diffuse proliferative LN and membranous LN are two
predominate pathologic findings in LN. SLE combined
with minimal change disease (MCD) has rarely been
reported. In this report, we describe the case of a patient
with SLE who had acute kidney injury (AKI) caused by
MCD. She was treated successfully with steroids with a
follow-up duration of 2 years.Case presentation
A 26-year-old Chinese woman with a history of SLE of
10 years presented to our hospital. Her initial symptoms* Correspondence: timmyclz@163.com
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and prolonged fever. The following were her laboratory
investigation results at that time: antinuclear antibody
(ANA) titer, 1:160 (+); anti-Smith (anti-Sm) antibody, +;
urinary protein level, 3+; hematuria, −; complement 3
value, 0.36g/L. Her renal function test and hematologic
evaluation results were within normal ranges. A renal
biopsy was not conducted at that time. Prednisolone
1mg/kg/day (40mg/day) was prescribed first and then
gradually tapered to 5mg/day over the course of 12 months.
The patient had complete remission of signs and symptoms
of SLE after the corticosteroid treatment. She took pred-
nisolone 5mg/day as maintenance therapy during the next
10 years.
When she was admitted to our hospital, she had a rap-
idly progressive edema and oliguria (urine output was
about 250ml/day). Her physical examination revealed
that she had mild edema of the face and legs. She had
not taken any drugs other than prednisolone within the
preceding 6 months. Her blood pressure level was 108/
71mmHg. Her heart and lungs were normal. No liver,
spleen or lymph node enlargement was found. Theis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Light microscopy of the patient’s renal biopsy tissue.
We found that 18 glomeruli were present in the sample. The glomeruli
show an almost normal appearance. The capillary lumina are patent.
The basement membranes are intact and not duplicated. The
mesangium is not widened and not proliferated. The interstitial space
shows a multifocal, mild mononuclear cell infiltration. The tubules are
minimally atrophic. The vessels are unremarkable. There is no obvious
chronic damage in the kidney. Hematoxylin and eosin stain; original
magnification, ×200.
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urinary protein, 3+; 24-hour urinary protein, 4.16g/day;
hematuria, −; blood urea nitrogen, 21.0mmol/L; creatinine,
455μmol/L; albumin, 22.8g/L; total cholesterol, 5.26mmol/
L; triglycerides, 1.45mmol/L; hemoglobin, 10.3g/dl; white
blood cell count, 3.08×109/L; red blood cell count,
3.53×1012/L; platelets, 81×109/L; ANA, 1:320 (+); comple-
ment 3, 0.60g/L; anti-DNA antibody–negative; anti-Sm
antibody–negative; anti-ribonucleoprotein-negative; hepa-
titis B surface antigen–negative; anti-hepatitis C virus–
negative; and anti-HIV-negative. Her chest digital
radiography and abdominal ultrasonography results were
normal. She did not have any other comorbid conditions
or recent infections. Within just 1 week, the patient’s
symptoms got worse, her edema became aggravated,
her urine output decreased to 50ml/day and her serum
creatinine level rose to 550μmol/L (Table 1).
Our first diagnostic impression was severe LN. A per-
cutaneous renal biopsy was performed on the patient’s
fourth hospital day. Unexpectedly, glomeruli showed an
almost normal appearance under light microscopy. The
capillary lumina were patent. The basement membranes
were intact and not duplicated. The mesangium was not
widened and was not proliferated. The intertitium space
showed a multifocal, mild mononuclear cell infiltration.
The tubules were minimally atrophic. The vessels were
unremarkable. There was no obvious chronic damage in
the kidney (Figure 1). Immunofluorescence microscopy
revealed an absence of deposits of immunoglobulin,
complements and fibrinogen. By electron microscopy,
we observed a marked effacement of the foot processes
of podocytes as well as a microvillous transformation.
The mesangial area was unremarkable. The basement
membrane was irregularly wrinkled. The capillary lumina
were patent. There were no electron deposits observed by
electron microscopy (Figure 2). With a diagnosis of MCD,
an “adequacy” dose steroid regimen (prednisolone 1mg/
kg/day, 50mg/day) was administered orally. Other adju-
vant therapies included hemodialysis, diuresis and supple-
mental plasma albumin.
A few days after the initiation of steroids, the patient’s
edema and her high serum creatinine level remitted slowly
(Figure 3). By the 17th day of therapy, her serumTable 1 Changes in multiple indicators during admissiona






1 455 22.8 250 1:320 0.31
4b 550 21.9 50 – –
10 184 24.6 750 – –
15 99.5 25 1500 – –
20 58.6 26.4 2000 1:100 0.6
aAlb, Albumin; ANA, Antinuclear antibody; C3, Complement 3; SCr, Serum
creatinine. bStart of prednisolone administration.creatinine level decreased to a normal level (58.6μmol/L),
and her serum albumin and urine output increased to
26.4g/L and 2000ml/24 hr, respectively (Table 1). She was
discharged from the hospital with improved symptoms
and signs. One month after she was discharged, laboratoryFigure 2 Electron microscopy of the patient’s renal biopsy.
This section shows a marked effacement of the foot processes of
podocytes as well as a microvillous transformation The mesangial
area is unremarkable. The basement membrane is irregularly
wrinkled. The capillary lumina are patent. No electron deposits are
visible. Uranyl acetate and lead citrate double-stain; original
magnification, ×15,000.
Figure 3 Changes in serum creatinine levels during admission.
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mal serum albumin levels. The dosage of oral steroids was
tapered gradually over the course of the next 10 months.
After continuous treatment, her nephrotic syndrome
resolved completely and no signs of relapse were noted
during 2 years of follow-up.
Discussion
SLE is a prototype autoimmune disease involving multiple
organs, with the kidney being most common. This disease
is known as LN. A large number of immune complex
depositions in the kidney are the main reason for the
onset of LN. A “full-house” phenomenon visualized under
an immunofluorescence microscope and electron-dense
deposits in the glomeruli are its main pathological features.
According to the International Society of Nephrology
and Renal Pathology Society (ISN/RPS) consensus, LN
is classified into types I to VI. The nephrotic syndromeTable 2 Literature review of patients with SLE and MCDa
Author Year Sex Age, yr SC
Matsumura et al. [10] 1989 F 37
F 21
F 22
Okai et al. [5] 1992 M 22
Makino et al. [11] 1995 F 41
Horita et al. [4] 1997 F 25
Nishihara et al. [12] 1997 F 17
Guery et al. [13] 1998 F 27
Perakis et al. [14] 1998 F 45
Seo et al. [8] 2002 F 41
Wang et al. [7] 2006 F 19
Hong et al. [6] 2011 F 24
Redondo-Pachón et al. [9] 2012 F 59
aMCD, Minimal change disease; n.d., No data SCr, serum creatinine; SLE, Systemic luis commonly associated with diffuse, proliferative LN
(ISN/RPS class IV) and membranous LN (ISN/RPS
class V) [2]. Our patient had a long history of SLE;
however, her renal biopsy findings and clinical course
were typical of MCD.
The coexistence of AKI, MCD and SLE, as we saw in
our patient, is extremely rare. Treatments for LN and
MCD are different. Patients with ISN/RPS class III or
IV LN should receive long-term aggressive therapy,
including high doses of daily oral corticosteroids, intra-
venous pulses of corticosteroids, intravenous pulses of
cyclophosphamide therapy, mycophenolate mofetil and
cyclosporine A, among other medications [3]. However,
treatments for MCD mainly involve oral corticosteroids
for 6 months to 1 year, possibly in addition to other
immunosuppressive therapies. The clinical diagnosis, prog-
nosis and treatment of LN should be assessed with the
support of a histological analysis, unless a renal biopsy is
performed, in which case administration of a cytotoxic
agent is unavoidable.
The presence of lupus and MCD in the same patient
may not be just a coincidence. In the literature, 13 cases
on the association between SLE and MCD have been
reported (Table 2) [4-9]. Among these cases, SLE devel-
oped simultaneously with the onset of MCD in five cases
and after the onset of MCD in three cases. MCD devel-
oped during the course of SLE in five patients. Among
these 13 patients, four patients combined with abnormal
renal function. Only one case was linked to nonsteroidal
anti-inflammatory drugs (NSAIDs); the rest of the patients
had no obvious secondary factors. After administration of
prednisolone or NSAID discontinuation, remission was
achieved in all patients. Their edema disappeared, their
serum creatinine decreased to normal levels and their
urinary protein turn to negative.r (mg/dl) Clinical course
n.d. SLE developed when MCD relapsed
n.d. SLE developed when MCD relapsed
n.d. SLE developed simultaneously with onset of MCD
n.d. SLE developed simultaneously with onset of MCD
1.51 MCD developed during course of SLE
n.d. SLE developed simultaneously with onset of MCD
0.5 SLE developed when MCD was in remission
3.41 SLE developed simultaneously with onset of MCD
1.1 MCD developed during course of SLE
2.2 SLE developed simultaneously with onset of MCD
1.9 MCD developed during course of SLE (NSAID-induced)
0.6 MCD developed during course of SLE
0.75 MCD developed during course of SLE
pus erythematosus.
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her initial diagnosis of lupus; regrettably, a renal biopsy
was not performed at that time. Thus, we were unable
to distinguish which lesion developed first or whether
they arose simultaneously. The association between MCD
and the concurrent presence of SLE is not absolutely clear.
Immune abnormalities, especially T-cell dysfunction, were
considered to be the common cause of SLE and MCD in
our patient. Patients with SLE with a renal involvement
have a low helper/suppressor T-cell ratio. In MCD, glom-
erular permeability factors derived from T cells, such as
interleukin 13, is known to increase glomerular permeabil-
ity [15]. There may be another pathogenic link, which is
known to be associated with genes coded within the major
histocompatibility complex between these two diseases. A
question remains whether SLE simply co-occurs with
MCD or is a precipitating agent of MCD.
Conclusion
We reported a case of AKI associated with MCD in a
patient with SLE. On the basis of our experience in this
case, we offer two suggestions. First, a renal biopsy should
be performed in patients with SLE to exclude other neph-
rotic diseases. Second, there may be an immunological
association between SLE and MCD. Further investigation
is needed to understand the relationship between SLE
and MCD.
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